Targeting the crosstalk between estrogen receptors and membrane growth factor receptors in breast cancer treatment: Advances and opportunities
Article in Biomedicine & Pharmacotherapy (April 2024)
The most recent citing publications are shown below. View all 89 publications that cite this research output on Dimensions.
Exploring FGFR signaling inhibition as a promising approach in breast cancer treatment
Article in International Journal of Biological Macromolecules (April 2024)
Sunitinib in Patients With Breast Cancer With FGFR1 or FGFR2 Amplifications or Mutations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Article in JCO Precision Oncology (February 2024)